Philanthropy White Paper

whitePaper | February 3, 2020

In 1990, domestic automobile manufacturers found themselves in deep trouble. The innovative design and the quality of production long associated with the three dominant American brands, Ford, General Motors and Chrysler, had long been consigned to the annals of memory. The autos that rolled off of the Detroit assembly lines were notoriously ill designed and were, in general, very unreliable. Additionally, the oil crisis of the 1970s, one that would drive the American consumer to more fuel efficient vehicles, prompted the production of domestic compact vehicles that could not compete with the new foreign imports of Toyota, Mazda and Honda.

whitePaper | December 10, 2019

Ask most board members if they were told they’d be responsible for fundraising when they joined the board and you’ll hear a lot of no’s. Somewhere in the recruitment process, the fundraising part of their job got downplayed. Maybe it wasn’t you, maybe it was a board member who let them off the hook.

whitePaper | July 4, 2022

The Kindly Ecosystem makes it easy to purchase, track and execute certified measurable social impact on the blockchain. It was built from the ground up to not only be transparent but to also satisfy the needs for Corporate Social Responsibility (CSR).

whitePaper | October 2, 2021

Disaster planning isn’t fun or exciting and it doesn’t directly help the people we aim to serve. However, it is essential for nonprofit organizations who want to remain resilient in the face of the unforeseen. Nonprofits provide a wide variety of services ranging from travel and leisure to educational and informational to health and direct services that may be crucial to their clients’ survival. Nonprofits provide essential services, and need to be prepared for the emergencies that may impact their operations or their ability to serve and fulfill their missions.

whitePaper | January 13, 2021

As nonprofits begin to emerge from the COVID-19 crisis, many priorities and concerns have shifted. In May, we sent a brief questionnaire to our database of thousands of nonprofits. The response was telling, and a clear picture of the challenges ahead surfaced from the organizations surveyed. This white paper details the survey results and what they mean for the future of nonprofits nationwide. Use the form here to have the whitepaper sent to your inbox!

whitePaper | January 29, 2020

To address high drug prices and the challenges they create for access to drugs, organizations have been exploring and working to create nonprofit pharmaceutical companies. These nonprofit companies prioritize drug access and affordability in the United States as core components of their mission. In the current federal policy landscape, however, there are specific incentives for the operation of for-profit pharmaceutical companies that do not similarly benefit their nonprofit counterparts, as well as several other barriers to sustainability for nonprofit companies.